癌に関する臨床報告

Hepatitis B

Female in the 60s
Chief Complaint: No significant symptoms
Past Medical History: Depression

Current Medical History:
She had received treatment for hepatitis B at another hospital for about 20 years. She had been intravenously given 5 ampoules of conservative treatment of liver sick drug (SMC) four days a week, however no improvement had been observed. She visited our clinic in August 2002. After the informed consent procedure, she began taking Fucoidan Mix AG as a treatment option without impairing the QOL.

Treatment outcomes:
After taking 1.0g of Fucoidan Mix AG per day, her levels of GOT were reduced to 9450, and her GPT levels were reduced to 79 from 36. She had received 5 ampoules of liver asylum agent (SMC) (intravenous injection) at the previous hospital. During the treatment at our hospital, the agent was reduced to 1 ampoule from 3 ampoules, then administration of SMC became no longer necessary 6 months later.

※Data taken over the period of treatment

【Biochemistry tests】
Fucoidan Mix AG intake per day: Approximately 1.0ｇ

SMC　5A→3A→1A→off（Half a year later）

当法人は、「抗がん作用」「コレステロール低下作用」「血圧低下作用」「抗ウイルス作用」など
さまざまな生理機能が解明されている「フコイダン」について研究を行なっています。